Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

AMD3100 for Sensitizing in Allogeneic Blood or Marrow Transplant for Chemotherapy Resistant Pediatric Acute Leukemia (BMTAMD3100)

This study has been terminated.
(lack of patient enrollment)
Information provided by (Responsible Party):
Kuang-Yueh Chiang, Emory University Identifier:
First received: July 27, 2012
Last updated: April 4, 2014
Last verified: April 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2014
  Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)